Science and Technology
publicado em 31/08/2010 às 21h00:00
   Dê o seu voto:

Identified genetic basis for determining the severity of allergic asthma

Research may help in the search for future therapeutic strategies to combat a growing problem of health

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Scientists at Cincinnati Children's Hospital Medical Center, USA, have identified a new genetic basis for determining the severity of allergic asthma in experimental models of disease. The study may help in the search for future therapeutic strategies to combat an increasing health problem that currently lacks effective treatments.

The prevalence of asthma has increased in recent years, according to the study's senior investigator, Marsha Wills-Karp. The disease can be triggered in susceptible people by a variety of environmental contaminants like cigarette smoke, allergens and air pollution.

The team of Wills-Karp found a molecular tipping point that disturbs the delicate balance between the base of mild and more severe asthma. They identified the pro-inflammatory proteins, interleukin-17 (IL-17A) as the main culprit behind severe asthma symptoms in mouse models.

"This study suggests that at some point it may be possible to treat or prevent severe forms of asthma, inhibiting pathways that lead to the production of IL-17A," said Wills-Karp.

The disease process seems to begin when the airway exposure to environmental allergens cause dysfunction in the regulation of a gene called factor com3 (C3), which runs through a part of the immune system called complement cascade activation. This leads to excess production of IL-17A cells in the airways and causes what scientists describe as a "cycle of amplification, when IL-17A in turn induces the production of more C3 on the surface of the airways.

The amplification cycle continues to increase inflammatory response involving T cells irregular, other proteins of interleukin (IL-13 and IL-23) as well as the response in excess of the airways and obstruction to airflow.

Previous studies demonstrated the presence of IL-17A protein in human asthma, but no apparent function. Previous research involving mouse models of disease suggest possible roles for IL-17A in asthma, and this study expands on those findings.

Source: Isaude.net
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Identified genetic basis for determining the severity of allergic asthma
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Identified genetic basis for determining the severity of allergic asthma


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
allergic asthma    IL-17A    Marsha Wills-Karp    Cincinnati Children's Hospital Medical Center   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.